LAETRILE: A STUDY OF ITS PHYSICOCHEMICAL AND BIOCHEMICAL PROPERTIES.
A study was made of the composition and biochemical behaviour of the drug, Laetrile, distributed for clinical trial in the United States and Canada. It was established that the Canadian and the American product are different pharmaceutical formulations, displaying different physicochemical and biochemical properties. The investigation demonstrated, furthermore, that neither preparation can be considered as a palliative in cancer therapy on the basis of the biological rationale advanced by their manufacturers.
D000678:Amygdalin; D000970:Antineoplastic Agents; D001669:Biochemical Phenomena; D001671:Biochemistry; D002170:Canada; D003486:Cyanides; D004358:Drug Therapy; D006801:Humans; D009369:Neoplasms / Q000628:therapy*; D010166:Palliative Care; D010600:Pharmacology; D014481:United States
D000970:Antineoplastic Agents; D003486:Cyanides; D000678:Amygdalin
ANTINEOPLASTIC AGENTS; BIOCHEMISTRY; CYANIDES; DRUG THERAPY; NEOPLASM THERAPY; PALLIATIVE TREATMENT; PHARMACOLOGY